Victor Sanchez - Pharma-Bio Serv CEO
PBSV Stock | USD 0.55 0.00 0.00% |
CEO
Mr. Victor Sanchez is the President, Chief Executive Officer of the Company., effective January 1, 2015. Mr. Sanchez has served as the President of the European Operations of the Company since January 2011. Prior to joining the Company, he served as Operations Manager in the LOCM and OSD divisions of Merck Sharp Dohme, a pharmaceutical company, in Madrid, Spain from April 2010 to January 2011 and as Operations Manager of the LOCM division of ScheringPlough S.A., a pharmaceutical company, in Madrid, Spain, from September 2004 to April 2010. He served as Quality Control Validations Manager for ScheringPlough Products, LLC, a pharmaceutical company, in Puerto Rico from December 2000 to August 2004 and as Quality Control Laboratory Supervisor of ScheringPlough from April 1996 to December 2000. Mr. Sanchez holds a BS in Chemistry, summa cum laude, and a M.B.A. in Industrial Management, cum laude, from the Interamerican University of Puerto Rico. He holds a Post Graduate Diploma in Pharmaceutical Validation Technology from the Dublin Institute of Technology, Ireland. Mr. Sanchez is a licensed chemist by the Puerto Rico State Department and a member of the American Chemical Society, the Parenteral Drug Association, the Regulatory Affairs Professional Society, and the International Society for Pharmaceutical Engineers. since 2015.
Age | 52 |
Tenure | 10 years |
Phone | 787 278 2709 |
Web | https://www.pharmabioserv.com |
Pharma-Bio Serv Management Efficiency
The company has return on total asset (ROA) of 0.033 % which means that it generated a profit of $0.033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0568 %, meaning that it created $0.0568 on every $100 dollars invested by stockholders. Pharma-Bio Serv's management efficiency ratios could be used to measure how well Pharma-Bio Serv manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 5 records | CEO Age | ||
Kevin Coop | Definitive Healthcare Corp | 60 | |
Hadi Chaudhry | CareCloud | 48 | |
Brent Ness | Aclarion | 57 | |
William Febbo | OPTIMIZERx Corp | 56 | |
Michael Hays | National Research Corp | 70 |
Management Performance
Return On Equity | 0.0568 | |||
Return On Asset | 0.033 |
Pharma Bio Serv Leadership Team
Elected by the shareholders, the Pharma-Bio Serv's board of directors comprises two types of representatives: Pharma-Bio Serv inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharma-Bio. The board's role is to monitor Pharma-Bio Serv's management team and ensure that shareholders' interests are well served. Pharma-Bio Serv's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharma-Bio Serv's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pedro Lasanta, CFO, VP of Fin. and Admin. and Secretary | ||
Victor Sanchez, CEO and President and President of European Operations | ||
Elizabeth Plaza, Founder, Chairman, Sr. Strategic Consultant and Member of Nominating Committee | ||
Miriam MBA, HR Mang |
Pharma-Bio Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Pharma-Bio Serv a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0568 | |||
Return On Asset | 0.033 | |||
Profit Margin | 0.05 % | |||
Operating Margin | 0.06 % | |||
Current Valuation | 4.87 M | |||
Shares Outstanding | 22.95 M | |||
Shares Owned By Insiders | 64.53 % | |||
Price To Earning | 10.00 X | |||
Price To Book | 1.15 X | |||
Price To Sales | 0.90 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharma-Bio OTC Stock Analysis
When running Pharma-Bio Serv's price analysis, check to measure Pharma-Bio Serv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma-Bio Serv is operating at the current time. Most of Pharma-Bio Serv's value examination focuses on studying past and present price action to predict the probability of Pharma-Bio Serv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma-Bio Serv's price. Additionally, you may evaluate how the addition of Pharma-Bio Serv to your portfolios can decrease your overall portfolio volatility.